Shing et al.
Anal. Calcd for C14H25O6N: C, 55.43; H, 8.31; N, 4.62. Found:
C, 55.04; H, 8.42, N, 4.43.
Hz), 4.11 (1H, dt, J ) 8.7, 2.7 Hz), 4.31 (1H, t, J ) 9.6 Hz); 13C
NMR δ 17.85, 17.96, 30.97, 38.94, 47.01, 48.36, 67.13, 71.00,
72.82, 74.04, 99.07, 99.96; 13C NMR (C6D6) δ 18.0, 18.2, 31.0,
40.0, 46.8, 47.9, 67.4, 67.7, 71.2, 73.6, 74.1, 99.1, 100.0; 13C
DEPT135 NMR (C6D6) δ 18.0 (+ve), 18.2 (+ve), 31.0 (-ve), 40.0
(-ve), 46.8 (+ve), 47.9 (+ve), 67.4 (+ve), 67.7 (+ve), 71.2 (+ve),
73.6 (+ve), 74.1 (+ve); MS (FAB) m/z (rel intensity) 304 ([MH]+,
28), 303 ([M]+, 14), 272 ([M - OCH3]+, 24), 154 (100), 137 (72),
69 (69), 55 (66); HRMS (FAB) calcd for C14H25O6N [MH]+
304.1755, found 304.175796.
5,6,7-Trideoxy-2,3-O-[(2S,3S)-2,3-dimethoxybutan-2,3-dioxy]-
r,â-D-arabino-hept-6-eneofuranose (30). Following the glycol
cleavage procedure for alkene 10, triol 22 (852 mg, 2.78 mmol)
was converted into lactol 30 (0.763 g) as a colorless oil. It was
used in the next step without characterization.
Silyl Ethers 28 and 29. A solution of a mixture of isoxazolidines
25 and 27 (643 mg, 2.12 mmol), imidazole (721 mg, 10.6 mmol),
and TBSCl (798 mg, 5.30 mmol) in dry DMF (4 mL) was stirred
at room temperature for 24 h. The mixture was quenched with
saturated NaHCO3 solution and the aqueous phase was extracted
with Et2O (2 × 20 mL). The combined organic extracts were
washed with brine, dried over anhydrous MgSO4, and filtered. The
filtrate was concentrated under reduced pressure and the residue
was purified by flash chromatography (hexane:Et2O, 1:2) to afford
first silyl ether 28 (708 mg, 80%) and second silyl ether 29 (172
mg, 19%) as white solids. Data for 28: mp 99-100 °C; [R]20
D
+103.8 (c 2.67, CHCl3); Rf 0.67 (hexane:EtOAc, 1:2); IR (thin film)
2952, 2857, 1463, 1373, 1252, 1129, 1037, 836 cm-1; 1H NMR δ
0.05 (3H, s), 0.09 (3H, s), 0.87 (9H, s), 1.28-1.29 (6H, 2s), 1.51
(1H, dt, J ) 14.1, 4.8 Hz), 1.88 (1H, ddd, J ) 14.7, 9.6, 5.4 Hz),
2.75 (3H, s), 2.78 (1H, t, J ) 8.4 Hz), 2.97-3.06 (1H, m), 3.28
(6H, s), 3.38 (1H, t, J ) 7.8 Hz), 3.55 (1H, dd, J ) 11.4, 6.3 Hz),
3.64 (1H, dd, J ) 11.4, 8.4 Hz), 3.92 (1H, q, J ) 5.1 Hz), 4.14
(1H, t, J ) 8.4 Hz); 13C NMR δ -4.4, -4.2, 18.1, 18.2, 18.4,
26.2, 33.1, 38.4, 45.7, 48.3, 48.5, 69.2, 69.5, 70.1, 71.3, 75.0, 99.4;
MS (EI) m/z (rel intensity) 418 ([MH]+, 12), 417 ([M]+, 40), 386
([M - OCH3]+, 17), 286 ([M - OTBS]+, 16), 85 (57), 75 (98), 57
(99), 43 (100); HRMS (EI) calcd for C20H39O6NSi [M]+ 417.2541,
found 417.253508.
Isoxazolidines 32, 33, 34, and 35. Following the INAC
procedure for lactol 23, lactol 30 (763 mg) was converted into a
mixture of isoxazolidines 32, 33, 34, and 35 (843 mg, 100% from
22) as a colorless oil.
Silyl Ethers 36, 37, and 38. Following the silylation procedure
for isoxazolidines 25 and 27, isoxazolidines 32, 33, 34, and 35 (843
mg, 2.78 mmol) were converted into silyl ethers 36, 37, and 38.
Purification by flash chromatography (hexane:EtOAc, 4:1 to 1:5)
afforded first silyl ether 37 (395 mg, 34%) as a colorless oil, second
silyl ether 38 (197 mg, 17%) as a colorless oil, third silyl ether 36
(309 mg, 27%) as a white solid, and finally the starting isoxazolidine
35 (232 mg, 20%) as a colorless oil.
Data for 29: mp 53-54 °C [R]20 +132.3 (c 2.65, CHCl3); Rf
D
0.60 (hexane:EtOAc, 1:2); IR (thin film) 2950, 1465, 1374, 1251,
Data for 36: mp 62-63 °C; [R]20D +100.7 (c 1.31, CHCl3); Rf
0.19 (hexane:EtOAc, 2:1); IR (thin film) 2951, 1462, 1375, 1253,
1
1127, 1036, 842, 777 cm-1; H NMR (C6D6) δ 0.13 (3H, s), 0.22
1
(3H, s), 1.01 (9H, s), 1.13 (1H, d, J ) 12.9 Hz), 1.36 (3H, s), 1.40
(3H, s), 1.79 (1H, ddd, J ) 14.7, 6.9, 4.2 Hz), 1.85-1.98 (1H, m),
2.39 (3H, s), 2.92 (1H, dd, J ) 7.5, 2.4 Hz), 3.10 (3H, s), 3.13
(3H, s), 3.36 (1H, dd, J ) 9, 2.7 Hz), 3.65 (1H, td, J ) 9.3, 7.2
1126, 1044, 838 cm-1; H NMR (C6D6) δ 0.12 (3H, s), 0.27 (3H,
s), 1.01 (9H, s), 1.18 (1H, ddd, J ) 15, 6.9, 3 Hz), 1.31 (3H, s),
1.39 (3H, s), 1.59 (1H, dd, J ) 15, 1.2 Hz), 2.40 (1H, pentet, J )
8.4 Hz), 2.74 (1H, t, J ) 7.8 Hz), 3.10 (3H, s), 3.33-3.37 (4H,
m), 3.84 (1H, q, J ) 3 Hz), 3.89 (1H, dd, J ) 9.6, 6.6 Hz), 4.13
(1H, dd, J ) 9.3, 6.6 Hz), 4.28 (1H, dd, J ) 10.5, 9.6 Hz); 13C
NMR δ -4.9, -4.4, 17.9, 18.2, 18.6, 26.2, 29.7, 38.3, 46.1, 48.1,
48.2, 65.9, 69.4, 69.6, 71.1, 71.2, 99.4, 99.6; MS (FAB) m/z (rel
intensity) 418 ([MH]+, 84), 417 ([M]+, 67), 386 ([M - OCH3]+,
17), 109 (57), 95 (79), 83 (81), 69 (100), 55 (98); HRMS (FAB)
calcd for C20H39O6NSi [MH]+ 418.2619, found 418.261484.
Hz), 4.12 (1H, dd, J ) 8.7, 2.4 Hz), 4.29 (1H, t, J ) 9.6 Hz); 13
C
NMR δ -4.8, -3.9, 17.8, 18.6, 26.2, 31.0, 42.3, 46.9, 48.2, 67.4,
68.6, 71.0, 72.9, 74.2, 98.8, 99.6; MS (FAB) m/z (rel intensity)
418 ([MH]+, 23), 417 ([M]+, 10), 386 ([M - OCH3]+, 46), 286
([M - OTBS]+, 12), 95 (60), 73 (75), 69 (83), 55 (100), 43 (66);
HRMS (FAB) calcd for C20H39O6NSi [MH]+ 418.2619, found
418.262570.
Isoxazolidine 25. To a solution of silyl ether 28 (29.0 mg, 0.0694
mmol) in THF (3 mL) was added a 1 M THF solution of TBAF
(0.14 mL, 0.139 mmol). The reaction mixture was stirred at room
temperature for 12 h and the solvent was removed under reduced
pressure. Flash chromatography of the residue (CHCl3:MeOH, 30:
1) afforded isoxazolidine 25 (21.0 mg, 100%) as a white solid:
mp 141-142 °C; [R]20D +144.8 (c 0.93, CHCl3); Rf 0.15 (EtOAc);
IR (thin film) 3445, 2950, 1123, 1035 cm-1; 1H NMR δ 1.32 (6H,
s), 1.66 (1H, ddd, J ) 15.9, 9.6, 6 Hz), 2.11 (1H, dt, J ) 14.4, 4.8
Hz), 2.48 (1H, br s), 2.67 (3H, s), 2.99 (1H, t, J ) 8.4 Hz), 3.08-
3.17 (1H, m), 3.29-3.30 (6H, 2s), 3.44 (1H, t, J ) 8.4 Hz), 3.46
(1H, d, J ) 9.0 Hz), 3.59 (1H, t, J ) 10.5 Hz), 3.86 (1H, td, J )
8.7, 5.4 Hz), 4.16 (1H, dd, J ) 9.3, 7.5 Hz); 13C NMR δ 18.0,
29.8, 37.7, 45.6, 48.4, 48.6, 67.3, 68.6, 68.8, 70.2, 74.0, 99.5, 99.6;
13C DEPT135 NMR δ 18.0 (+ve), 29.8 (-ve), 37.7 (+ve), 45.6
(+ve), 48.4 (+ve), 48.6 (+ve), 67.3 (+ve), 68.6 (+ve), 68.8 (+ve),
70.2 (-ve), 74.0 (+ve); MS (FAB) m/z (rel intensity) 304 ([MH]+,
65), 303 ([M]+, 65), 272 ([M - OCH3]+, 42), 154 (77), 55 (100);
HRMS (FAB) calcd for C14H25O6N [MH]+ 304.1755, found
304.176525.
Isoxazolidine 27. According to the desilylation procedure for
silyl ether 28, silyl ether 29 (91.3 mg, 0.219 mmol) gave
isoxazolidine 27 (66.2 mg, 100%) as a white solid: mp 207-208
°C; [R]20D +220.9 (c 1.10, CHCl3); Rf 0.18 (EtOAc); IR (thin film)
3415, 2961, 1462, 1378, 1125, 1026 cm-1; 1H NMR (C6D6) δ 1.08
(1H, d, J ) 13.2 Hz), 1.21 (3H, s), 1.35 (3H, s), 1.85 (1H, ddd, J
) 12.9, 9.3, 8.1 Hz), 1.96 (1H, dd, J ) 8.1, 3 Hz), 2.34 (3H, s),
2.88 (1H, dd, J ) 7.8, 2.7 Hz), 2.95 (3H, s), 3.08 (3H, s), 3.21
(1H, br s), 3.33 (1H, dd, J ) 9, 2.7 Hz), 3.60 (1H, td, J ) 9.9, 8.4
Data for 37: [R]20 +91.5 (c 0.70, CHCl3); Rf 0.54 (hexane:
D
EtOAc, 2:1); IR (thin film) 2946, 2763, 375, 1251, 1133, 837, 775
1
cm-1; H NMR δ 0.04 (3H, s), 0.10 (3H, s), 0.87 (9H, s), 1.23
(3H, s), 1.26 (3H, s), 1.43 (1H, td, J ) 12.9, 2.1 Hz), 1.80 (1H, dt,
J ) 13.2, 3.3 Hz), 2.33 (1H, t, J ) 10.2 Hz), 2.93-3.01 (1H, m),
3.19 (3H, s), 3.22 (3H, s), 3.49 (1H, dd, J ) 9.6, 2.4 Hz), 3.61
(1H, dd, J ) 11.1, 6 Hz), 3.96 (1H, t, J ) 6.6 Hz), 4.04 (1H, q, J
) 2.7 Hz), 4.10 (1H, t, J ) 9.6 Hz); 13C NMR δ -4.8, -4.3, 18.0,
18.2, 18.6, 26.1, 32.5, 42.8, 47.6, 48.0, 48.1, 68.9, 69.5, 69.6, 72.8,
73.1, 99.2, 100.2; MS (FAB) m/z (rel intensity) 418 ([MH]+, 100),
417 ([M]+, 70), 386 ([M - OCH3]+, 12), 101 (25), 73 (43); HRMS
(FAB) calcd for C20H39O6NSi [MH]+ 418.2619, found 418.261854.
Data for 38: [R]20 +62.4 (c 1.41, CHCl3); Rf 0.38 (hexane:
D
EtOAc, 2:1); IR (thin film) 2951, 2855, 1125, 1040, 836 cm-1; 1H
NMR δ 0.03 (3H, s), 0.09 (3H, s), 0.91 (9H, s), 1.23 (3H, s), 1.25
(3H, s), 1.45 (1H, ddd, J ) 15, 4.5, 1.5 Hz), 2.01 (1H, dt, J )
15.3, 3.3 Hz), 2.22 (1H, d, J ) 13.2 Hz), 2.48 (1H, dt, J ) 13.5,
8.4 Hz), 2.62 (3H, s), 3.09 (1H, d, J ) 6.9 Hz), 3.20 (3H, s), 3.22
(3H, s), 3.64 (1H, dd, J ) 9.6, 1.2 Hz), 3.97 (1H, t, J ) 2.1 Hz),
4.28 (1H, d, J ) 9.3 Hz), 4.58 (1H, dd, J ) 8.7, 4.5 Hz); 13C NMR
δ -4.9, -4.4, 17.7, 18.1, 18.6, 26.2, 32.2, 39.9, 47.9, 48.1, 68.5,
72.0, 76.3, 99.1, 99.3; MS (FAB) m/z (rel intensity) 418 ([MH]+,
100), 417 ([M]+, 76), 386 ([M - OCH3]+, 20), 154 (53), 95 (56),
69 (67), 55 (69); HRMS (FAB) calcd for C20H39O6NSi [MH]+
418.2619, found 418.262098.
Data for 35: [R]20 +169.4 (c 1.72 CHCl3); Rf 0.38 (EtOAc:
D
MeOH, 10:1); IR (thin film) 3432, 2948, 1127, 1039, 756 cm-1
;
1H NMR (C6D6) δ 1.31 (3H, s), 1.40 (3H, s), 1.72 (1H, ddd, J )
15.6, 3.6, 1.2 Hz), 1.89 (1H, dd, J ) 15.6, 5.1 Hz), 2.04 (1H, dt,
3262 J. Org. Chem., Vol. 71, No. 8, 2006